{
    "SPADE_UN_25688": {
        "Sequence Information": {
            "Peptide Name": "Daptomycin 3g",
            "Sequence": "WNDTGXDADGSXX",
            "Sequence Length": 13,
            "Biological Activity": [
                "Anti-Gram+"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Structure-Activity Relationship Studies of a Series of Semisynthetic Lipopeptides Leading to the Discovery of Surotomycin, a Novel Cyclic Lipopeptide Being Developed for the Treatment of Clostridium difficile-Associated Diarrhea.",
                    "Pubmed ID": "25993059",
                    "Reference": "J Med Chem. 2015;58:5137-5142",
                    "Author": "Yin N, Li J, He Y, Herradura P, Pearson A, Mesleh MF, Mascio CT, et al.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/25993059"
                }
            ],
            "SPADE ID": "SPADE_UN_25688",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_05600",
                    "Similarity": 1.0,
                    "Sequence": "WNDTGKDADGSEY"
                },
                {
                    "SPADE_ID": "SPADE_UN_25580",
                    "Similarity": 1.0,
                    "Sequence": "WNDTGDADGSEW"
                },
                {
                    "SPADE_ID": "SPADE_UN_25582",
                    "Similarity": 1.0,
                    "Sequence": "WNDTGDADGSEY"
                }
            ],
            "Hemolytic Activity": "",
            "Target Organism": "Clostridioides difficile(MIC90=0.5µg/ml),Staphylococcus aureus ATCC 29213(MIC=0.5µg/ml),Enterococcus faecium ATCC 6569(MIC=16µg/ml),Enterococcus faecalis ATCC 49452(MIC=>32µg/ml)"
        }
    }
}